AMC: Analysts Call For EPS Of -$0.19 In Q2

AMC Entertainment Holdings, Inc. (NYSE: AMC) will report its second quarter financial results on August 4th after market close. Analysts have a consensus $9.09 12-month price target on the company, via a total of 8 analysts, with 3 analysts having hold ratings, 3 analysts have sell ratings and the last 2 analysts have strong sell ratings on the stock.

Seven analysts have revenue estimates for the second quarter. The mean revenue estimate between all seven analysts is $1.18 billion; this number has been revised downwards from $1.25 billion at the start of the year. The highest revenue estimate is $1.28 billion, while the lowest is $1.1 billion.

Onto EBITDA estimates, there are currently seven analysts who have second quarter EBITDA estimates. The mean is currently $78.9 million, with this number having been revised downwards from $148 million at the start of the year. Street high is a $126.6 million EBITDA estimate and the lowest is $15.9 million.

Analysts estimate that quarterly earnings per share will come in at -$0.19, with this number being revised downwards from -$0.11 at the start of the year. The street high estimate is -$0.09 and the lowest estimate is -$0.36 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Everybody Should Own Gold | George Bee – U.S. Gold Corp.

A $40M Company Created $2B in Mining Value | John-Mark Staude – Riverside Resources

The Debt Crisis Is Turning Gold Into Money | Shawn Khunkhun – Contango Silver and Gold

Recommended

Epic Gold Assays 9.42 g/t Gold Over 11 Metres at Hawkins In Trenching, Links Occurrences Along 15 Kilometre Corridor

Goliath Cuts 28.81 g/t Gold Equivalent Over 4 Metres Within Broader Surebet Intercept

Related News

Canaccord: Meta Platforms’ Near Term Headwinds Are Priced In

On October 25th, Facebook (NASDAQ: FB), now called Meta Platforms, reported their 2021 third quarter...

Thursday, November 4, 2021, 05:08:00 PM

Organigram: Analysts Upgrade Targets Following BAT Investment

On March 9th, Organigram Holdings (TSX: OGI) (NASDAQ: OGI) announced that they received a C$221...

Sunday, March 14, 2021, 06:32:00 PM

Dollarama: Analysts Anticipate $972.5 Million In Q1 2022 Revenue

Dollarama Inc (TSX: DOL) will be reporting its first quarter 2022 financial results on June...

Tuesday, June 8, 2021, 05:06:00 PM

Antibe: Canaccord Cuts Price Target From $5.00 To $1.20 After Drug Pivot

In early August, Antibe Therapeutics Inc. (TSX: ATE) announced that they have paused their study...

Monday, October 18, 2021, 11:31:00 AM

Columbia Care: Canaccord Drops Price Target To $13

On November 12th, Columbia Care (NEO: CCHW) reported its third quarter financial results. The company...

Sunday, November 21, 2021, 04:52:00 PM